Pharmacy

Your Article Summary

See Latest Articles

High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome
Diseases of the Esophagus, 08/03/09

Hurmuzlu M et al. – The results of study have shown that concurrent high–dose chemoradiotherapy provides long–term local tumor control in locally advanced esophageal cancer. However, toxicities following this high–dose treatment, while manageable, were significant. Survival rates were not improved by high–dose chemoradiotherapy compared with what is reported in previous studies applying lower doses of definitive chemoradiotherapy.

Today in Chemotherapy/Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer
Annals of Internal Medicine, 11/17/09

Current status of maintenance therapy for advanced ovarian cancer
International Journal of Women's Health, 11/03/09

Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations
Cancer Management and Research, 11/05/09

See All of Chemotherapy/Oncology

Today in Dosing...keeping you current

Receive free subspecialty "5-minute updates" via email

Drug dosage protocol for calcium oxalate stone
Urological Research - Urolithiasis, 10/23/09

Telavancin: A Novel Lipoglycopeptide
Clinical Infectious Diseases, 11/16/09

Risperidone dose for schizophrenia
Cochrane Reviews, 10/21/09

See All of Dosing

Today in Stomach/GI...keeping you current

Receive free subspecialty "5-minute updates" via email

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09

Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin
Journal of Viral Hepatitis, 11/09/09

Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09

See All of Stomach/GI